LENSAR (LNSR) Projected to Release Earnings on Thursday

LENSAR (NASDAQ:LNSR) is expected to be announcing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect LENSAR to announce earnings of ($0.1650) per share and revenue of $14.65 million for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 12:30 PM ET.

LENSAR (NASDAQ:LNSR) last issued its earnings results on Friday, May 8th. The company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $1.38. The business had revenue of $13.43 million for the quarter, compared to the consensus estimate of $13.40 million. LENSAR had a net margin of 50.94% and a negative return on equity of 183.19%.

LENSAR Trading Down 1.9%

NASDAQ:LNSR opened at $5.25 on Thursday. The firm has a market capitalization of $64.47 million, a price-to-earnings ratio of -9.05 and a beta of 0.87. The firm’s fifty day simple moving average is $5.83 and its 200 day simple moving average is $7.83. LENSAR has a twelve month low of $5.06 and a twelve month high of $13.31.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on LNSR shares. Wall Street Zen downgraded LENSAR from a “hold” rating to a “sell” rating in a report on Saturday, May 16th. Lake Street Capital upgraded LENSAR from a “hold” rating to a “buy” rating and set a $10.00 price objective on the stock in a research note on Wednesday, April 1st. Finally, Weiss Ratings raised LENSAR from a “sell (d-)” rating to a “sell (d+)” rating in a research report on Monday, May 11th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, LENSAR has a consensus rating of “Hold” and a consensus price target of $10.00.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in LNSR. BNP Paribas Financial Markets boosted its stake in shares of LENSAR by 129.0% in the third quarter. BNP Paribas Financial Markets now owns 2,008 shares of the company’s stock valued at $25,000 after purchasing an additional 1,131 shares during the period. JPMorgan Chase & Co. grew its holdings in LENSAR by 584.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 4,674 shares of the company’s stock valued at $62,000 after purchasing an additional 3,991 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in LENSAR during the 2nd quarter worth $68,000. New York State Common Retirement Fund purchased a new stake in LENSAR during the 2nd quarter worth $105,000. Finally, Dynamic Technology Lab Private Ltd acquired a new position in LENSAR in the 3rd quarter worth $125,000. 40.15% of the stock is owned by institutional investors and hedge funds.

About LENSAR

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.